St. Lawrence Health System

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, St. Lawrence Health System sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials 1 currently recruiting upper half by trial count

St. Lawrence Health System: 2 sponsored US clinical trials, 1 recruiting.

St. Lawrence Health System sponsors 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Rheumatoid Arthritis (RA), with 1 trials.

Mid-pack sponsor footprint

St. Lawrence Health System is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

What is open in the St. Lawrence Health System pipeline

1 recruiting of 2 indexed (50% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Rheumatoid Arthritis (RA) (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

St. Lawrence Health System: open-pipeline peers nationwide

Peers matched on 2 registered trials and 50% open enrollment, not the therapeutic-area sidebar.

St. Lawrence Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%20%40%60% Total trials Recruiting share St. Lawrence Health System1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health3ive Labs60 Degrees Pharmaceuticals7 Hills PharmaAbcentra
St. Lawrence Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

St. Lawrence Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 trials (± recruiting share)

Sponsors near 50% open enrollment (± trial volume)

What to do with this St. Lawrence Health System page

2 registered trials is a research-attention snapshot, not an endorsement of St. Lawrence Health System or any single study.

  • 1 of St. Lawrence Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Rheumatoid Arthritis (RA) is the condition St. Lawrence Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Rheumatoid Arthritis (RA) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

St. Lawrence Health System pipeline card: 2 registered trials from official public datasets.Report a data error.